These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7700043)

  • 1. Peritoneal host defense mechanisms in peritoneal dialysis.
    Holmes CJ
    Kidney Int Suppl; 1994 Dec; 48():S58-70. PubMed ID: 7700043
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritonitis during continuous ambulatory peritoneal dialysis: the role of host defense mechanisms.
    Keane WF; Peterson PK
    Trans Am Soc Artif Intern Organs; 1984; 30():684-6. PubMed ID: 6533956
    [No Abstract]   [Full Text] [Related]  

  • 3. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 2. Humoral defenses.
    Holmes C; Lewis S
    Perit Dial Int; 1991; 11(2):112-7. PubMed ID: 1854866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
    de Fijter CW; Verbrugh HA; Oe PL; Heezius EC; Verhoef J; Donker AJ
    Nephrol Dial Transplant; 1994; 9(2):156-62. PubMed ID: 8190329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
    Cameron JS
    Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucose concentration and dwell time of dialysis fluid on the antibacterial defense in the peritoneal cavity of rats.
    Calame W; Hendrickx RJ; Oe LP; Namavar F; Beelen RH
    Adv Perit Dial; 1992; 8():219-22. PubMed ID: 1361790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function.
    Alobaidi HM; Coles GA; Davies M; Lloyd D
    Nephrol Dial Transplant; 1986; 1(1):16-21. PubMed ID: 3110659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain differences in the opsonisation of Staphylococcus epidermidis.
    Bennett-Jones DN; Yewdall VM; Gillespie CM; Ogg CS; Cameron JS
    Perit Dial Int; 1989; 9(4):333-9. PubMed ID: 2488390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.
    Topley N; Williams JD
    Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of mesothelial cells in peritoneal antibacterial defence.
    Muijsken MA; Heezius HJ; Verhoef J; Verbrugh HA
    J Clin Pathol; 1991 Jul; 44(7):600-4. PubMed ID: 1856294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialysate fluids on phagocytosis and killing by normal neutrophils.
    Harvey DM; Sheppard KJ; Morgan AG; Fletcher J
    J Clin Microbiol; 1987 Aug; 25(8):1424-7. PubMed ID: 3624441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological defenses in CAPD.
    Lamperi S; Carozzi S
    Blood Purif; 1989; 7(2-3):126-43. PubMed ID: 2663033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucose in dialysis fluid on antibacterial defence in the peritoneal cavity.
    Calame W; Hendrickx RJ; Namavar F; Oe LP; Beelen RH
    J Infect; 1995 May; 30(3):227-33. PubMed ID: 7673747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytic defence against CAPD peritonitis. The bacterium, the phagocyte, and the doctor.
    Verbrugh HA; van Bronswijk H; van der Meulen J; Oe PL; Verhoef J
    Contrib Nephrol; 1987; 57():85-91. PubMed ID: 3677705
    [No Abstract]   [Full Text] [Related]  

  • 20. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
    Gordon DL; Rice JL; Avery VM
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.